Small molecule-driven SIRT3-autophagy-mediated NLRP3 inflammasome inhibition ameliorates inflammatory crosstalk between macrophages and adipocytes.


Journal

British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536

Informations de publication

Date de publication:
10 2020
Historique:
received: 19 12 2019
revised: 03 06 2020
accepted: 15 07 2020
pubmed: 30 7 2020
medline: 22 6 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

IL-1β produced by macrophages via the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome, mediates the inflammatory crosstalk between macrophages and adipocytes. In our previous study, (16S,20S,24R)-12β-acetoxy-16,23-epoxy-24,25-dihydroxy-3β-(β-D-xylopyranosyloxy)-9,19-cyclolanost-22(23)-ene (AEDC), a cycloartane triterpenoid isolated from Actaea vaginata (Ranunculaceae), was found to possess anti-inflammatory effect on LPS-treated RAW264.7 macrophages. This study was designed to investigate whether AEDC modulates macrophage-adipocyte crosstalk to alleviate adipose tissue inflammation. The anti-inflammatory effect of AEDC was evaluated on LPS plus ATP-induced THP-1 macrophages and C57BL/6J mice. The expression of autophagy-related and NLRP3 inflammasome complex proteins was analysed by western blots, immunofluorescence staining and co-immunoprecipitation. The pro-inflammatory cytokines levels were determined by ELISA kits. The adipose tissue inflammation was evaluated by histological analysis and immunohistochemical staining. AEDC (5 and 10 μM) activated autophagy, which in turn suppressed the NLRP3 inflammasome activation and IL-1β secretion in THP-1 macrophages. AEDC increased the expression of SIRT3 deacetylase and enhanced its deacetylating activity to reverse mitochondrial dysfunction and activate AMP-activated protein kinase, which together induced autophagy. Moreover, AEDC (10 μM) attenuated macrophage conditioned medium-induced inflammatory responses in adipocytes and blocked THP-1 macrophages migration towards 3T3-L1 adipocytes. In inflammation mice, AEDC (5 and 20 mg·kg AEDC attenuated the inflammatory crosstalk between macrophages and adipocytes through SIRT3-autophagy-mediated NLRP3 inflammasome inhibition, which might used for the treatment of adipose tissue inflammation-related metabolic disorders.

Sections du résumé

BACKGROUND AND PURPOSE
IL-1β produced by macrophages via the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome, mediates the inflammatory crosstalk between macrophages and adipocytes. In our previous study, (16S,20S,24R)-12β-acetoxy-16,23-epoxy-24,25-dihydroxy-3β-(β-D-xylopyranosyloxy)-9,19-cyclolanost-22(23)-ene (AEDC), a cycloartane triterpenoid isolated from Actaea vaginata (Ranunculaceae), was found to possess anti-inflammatory effect on LPS-treated RAW264.7 macrophages. This study was designed to investigate whether AEDC modulates macrophage-adipocyte crosstalk to alleviate adipose tissue inflammation.
EXPERIMENTAL APPROACH
The anti-inflammatory effect of AEDC was evaluated on LPS plus ATP-induced THP-1 macrophages and C57BL/6J mice. The expression of autophagy-related and NLRP3 inflammasome complex proteins was analysed by western blots, immunofluorescence staining and co-immunoprecipitation. The pro-inflammatory cytokines levels were determined by ELISA kits. The adipose tissue inflammation was evaluated by histological analysis and immunohistochemical staining.
KEY RESULTS
AEDC (5 and 10 μM) activated autophagy, which in turn suppressed the NLRP3 inflammasome activation and IL-1β secretion in THP-1 macrophages. AEDC increased the expression of SIRT3 deacetylase and enhanced its deacetylating activity to reverse mitochondrial dysfunction and activate AMP-activated protein kinase, which together induced autophagy. Moreover, AEDC (10 μM) attenuated macrophage conditioned medium-induced inflammatory responses in adipocytes and blocked THP-1 macrophages migration towards 3T3-L1 adipocytes. In inflammation mice, AEDC (5 and 20 mg·kg
CONCLUSION AND IMPLICATIONS
AEDC attenuated the inflammatory crosstalk between macrophages and adipocytes through SIRT3-autophagy-mediated NLRP3 inflammasome inhibition, which might used for the treatment of adipose tissue inflammation-related metabolic disorders.

Identifiants

pubmed: 32726464
doi: 10.1111/bph.15215
pmc: PMC7520450
doi:

Substances chimiques

Inflammasomes 0
Interleukin-1beta 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
Nlrp3 protein, mouse 0
Sirt3 protein, mouse 0
Sirtuin 3 EC 3.5.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4645-4665

Subventions

Organisme : Zhejiang Provincial Natural Science Foundation of China
ID : LR17H300001
Organisme : University of Macau
ID : MYRG2018-00037-ICMS
Organisme : University of Macau
ID : MYRG2017-00109-ICMS
Organisme : Science and Technology Development Fund, Macau SAR
ID : FDCT 0031/2019/A1
Organisme : National Natural Science Foundation of China
ID : 81872754
Organisme : National Natural Science Foundation of China
ID : 81872756

Informations de copyright

© 2020 The British Pharmacological Society.

Références

Nature. 2008 Nov 13;456(7219):264-8
pubmed: 18849965
Br J Pharmacol. 2019 Oct;176(20):3983-4001
pubmed: 31339170
Cell. 2010 Mar 19;140(6):821-32
pubmed: 20303873
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
Science. 2013 Jul 5;341(6141):84-7
pubmed: 23828940
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Obesity (Silver Spring). 2013 Nov;21(11):2322-30
pubmed: 23408599
Obesity (Silver Spring). 2007 Mar;15(3):664-72
pubmed: 17372317
Br J Pharmacol. 2019 Dec;176 Suppl 1:S1-S20
pubmed: 31710719
J Biomed Sci. 2017 Aug 24;24(1):60
pubmed: 28836970
Future Lipidol. 2008;3(5):545-556
pubmed: 18978945
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):429-444
pubmed: 30793539
Nat Immunol. 2011 Mar;12(3):222-30
pubmed: 21151103
Am J Physiol Endocrinol Metab. 2014 Aug 1;307(3):E289-304
pubmed: 24918199
Nat Protoc. 2014 Sep;9(9):2100-22
pubmed: 25101824
Cell Death Dis. 2017 Oct 26;8(10):e3158
pubmed: 29072685
Cell Death Dis. 2018 Jan 23;9(2):81
pubmed: 29362447
Br J Pharmacol. 2018 May;175(10):1590-1606
pubmed: 29446826
Cell Metab. 2012 Apr 4;15(4):534-44
pubmed: 22440612
Br J Pharmacol. 2018 Apr;175(7):987-993
pubmed: 29520785
Cell Death Differ. 2020 Jan;27(1):329-344
pubmed: 31160717
Int J Mol Sci. 2020 Jan 07;21(2):
pubmed: 31936019
J Nat Prod. 2018 Jun 22;81(6):1468-1473
pubmed: 29799195
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2062-8
pubmed: 16123319
Mol Endocrinol. 2016 Mar;30(3):325-34
pubmed: 26789108
Curr Pharm Des. 2006;12(3):287-311
pubmed: 16454745
Nat Med. 2011 Feb;17(2):179-88
pubmed: 21217695
Immunity. 2004 Mar;20(3):319-25
pubmed: 15030775
Oncotarget. 2017 Jun 20;8(25):40817-40831
pubmed: 28489580
Am J Physiol Endocrinol Metab. 2012 Jun 15;302(12):E1550-9
pubmed: 22454293
Nat Rev Immunol. 2010 Dec;10(12):826-37
pubmed: 21088683
Autophagy. 2014;10(11):1906-20
pubmed: 25483962
Br J Pharmacol. 2018 Feb;175(3):407-411
pubmed: 29350411
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Ann N Y Acad Sci. 2010 Nov;1212:E1-E19
pubmed: 21276002
Nature. 2011 Jan 20;469(7330):323-35
pubmed: 21248839
J Biol Chem. 2017 Jul 21;292(29):12153-12164
pubmed: 28584055
Nat Rev Immunol. 2013 Jun;13(6):397-411
pubmed: 23702978
Front Immunol. 2014 Jun 25;5:300
pubmed: 25009542
Phytochemistry. 2019 Apr;160:1-10
pubmed: 30641334
Trends Immunol. 2005 Oct;26(10):523-8
pubmed: 16099218
Cell. 2010 Mar 19;140(6):784-90
pubmed: 20303869
Int J Mol Sci. 2017 Aug 28;18(9):
pubmed: 28846632
Br J Pharmacol. 2020 Oct;177(20):4645-4665
pubmed: 32726464
Autophagy. 2016 Aug 2;12(8):1390-403
pubmed: 27337687
Nat Rev Immunol. 2007 Oct;7(10):767-77
pubmed: 17767194
Mol Nutr Food Res. 2012 May;56(5):725-32
pubmed: 22648619
J Nat Med. 2018 Sep;72(4):882-889
pubmed: 29752578
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):764-777
pubmed: 29277324
Nature. 2011 Jan 13;469(7329):221-5
pubmed: 21124315
Nat Rev Immunol. 2010 Feb;10(2):89-102
pubmed: 20081871
Nat Immunol. 2012 Jan 29;13(3):255-63
pubmed: 22286270
J Cell Sci. 2000 Nov;113 ( Pt 22):3907-19
pubmed: 11058078
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13998-4003
pubmed: 19666548
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Crit Rev Food Sci Nutr. 2020 May 28;:1-19
pubmed: 32462898
Br J Pharmacol. 2015 Jul;172(13):3189-93
pubmed: 25964986
Curr Opin Immunol. 2010 Feb;22(1):28-33
pubmed: 20060699
J Clin Invest. 2011 Jun;121(6):2111-7
pubmed: 21633179

Auteurs

Tian Zhang (T)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Macau, China.

Zhujun Fang (Z)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

Ke-Gang Linghu (KG)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Macau, China.

Jingxin Liu (J)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Macau, China.

Lishe Gan (L)

School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

Ligen Lin (L)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Macau, China.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH